Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Other Accumulated Expenses (2025 - 2026)

IM Cannabis has reported Other Accumulated Expenses over the past 2 years, most recently at $3.8 million for Q1 2026.

  • For Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $3.8 million; the TTM value through Mar 2026 reached $3.8 million, changed N/A, while the annual FY2025 figure was $4.4 million, N/A changed from the prior year.
  • Other Accumulated Expenses was $3.8 million for Q1 2026 at IM Cannabis, down from $4.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $4.4 million in Q4 2025 and bottomed at $3.8 million in Q1 2026.